PRR15 and neoplasm: In contrast, PRR15 knockdown did not exacerbate the initiation and progression of non-TNBC MCF7 cells in NOG mice, and no marked differences were observed between PRR15-silenced xenografts and controls in terms of tumor volume, tumor weight, and mouse body weight (Fig. S6h-k).